Member access

4-Traders Homepage  >  Shares  >  SHANGHAI STOCK EXCHANGE  >  Jiangzhong Pharmaceutical Co.,Ltd    600750   CNE000000M80

End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 06/19
20.21 CNY   -0.64%
SummaryQuotesChart AnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Jiangzhong Pharmaceutical  : Income Statement Evolution
Annual Income Statement Data
Actuals in M CNY Estimates in M CNY
Fiscal Period December 201020112012201320142015
Sales2 5632 6473 1923 7514 2414 801
Operating income (EBITDA)385345344496629-
Operating profit (EBIT)311-268414491567
Pre-Tax Profit (EBT)303277269379437567
Net income261228225319368478
EPS ( CNY)0,880,730,721,021,181,54
Dividend per Share ( CNY)--0,300,330,47-
Yield--1,47%1,62%2,31%-
Announcement Date03/30/2011
01:26am
01/16/2012
10:30pm
02/06/2013
12:49pm
---
Finances - Leverage
Jiangzhong Pharmaceutical  : Finances - Leverage
Actuals in M CNY Estimates in M CNY
Fiscal Period December 201020112012201320142015
Debt------
Finance--223510688-
Operating income (EBITDA)385345344496629-
Leverage
(Debt/EBITDA)
------
Capital Expenditure-24822483,290,248,0
Book Value Per Share (BVPS)5,57  CNY6,00  CNY6,43  CNY7,45  CNY8,49  CNY10,2  CNY
Cash Flow per Share0,75  CNY0,54  CNY0,73  CNY---
Announcement Date03/30/2011
01:26am
01/16/2012
10:30pm
02/06/2013
12:49pm
---
Balance Sheet Analysis
Jiangzhong Pharmaceutical  : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 6 329 M CNY -
Company Value 5 819 M CNY 5 641 M CNY
Valuation 2013e 2014e
PER (Price / EPS) 19,9x 17,2x
Capitalization / Revenue 1,69x 1,49x
EV / Revenue 1,55x 1,33x
EV / EBITDA 11,7x 8,97x
Yield (DPS / Price) 1,62% 2,31%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 11,0% 11,6%
operating laverage (Delta EBIT / Delta Sales) 3,12x 1,43x
Net Margin (Net Profit / Revenue) 8,49% 8,67%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 15,5% 16,3%
Rate of Dividend 32,3% 39,7%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   2,22% 2,13%
Cash Flow / Sales (Taux d'autofinancement) - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -1,03x -1,09x
Price Earning Ratio
Jiangzhong Pharmaceutical  : Price Earning Ratio
EPS & Dividend
Jiangzhong Pharmaceutical  : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.